189 related articles for article (PubMed ID: 23039833)
1. Introduction to special issue on Alzheimer's disease.
Wolfe MS
J Med Chem; 2012 Nov; 55(21):8977-8. PubMed ID: 23039833
[No Abstract] [Full Text] [Related]
2. Effect of the beta secretase-1 inhibitor on the amyloid C-terminal fragment of amyloid precursor protein processing in a hyperphosphorylated tau rat model.
Chen HY; Wang L; Liu JF; Wang WZ; Yu CJ
Genet Mol Res; 2014 Aug; 13(3):6213-27. PubMed ID: 25158248
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide reduces mRNA and protein levels of β-site amyloid precursor protein cleaving enzyme 1 in PC12 cells.
Zhang H; Gao Y; Zhao F; Dai Z; Meng T; Tu S; Yan Y
Neurochem Int; 2011 Feb; 58(2):169-75. PubMed ID: 21095213
[TBL] [Abstract][Full Text] [Related]
4. Bad news and good news in AD, and how to reconcile them.
Knopman DS
Nat Rev Neurol; 2019 Feb; 15(2):61-62. PubMed ID: 30622292
[No Abstract] [Full Text] [Related]
5. Membrane trafficking pathways in Alzheimer's disease.
Rajendran L; Annaert W
Traffic; 2012 Jun; 13(6):759-70. PubMed ID: 22269004
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer disease: BACE1 inhibitor reduces β-amyloid production in humans.
Crunkhorn S
Nat Rev Drug Discov; 2016 Dec; 16(1):18. PubMed ID: 28031572
[No Abstract] [Full Text] [Related]
8. Synthesis and evaluation of arylquinones as BACE1 inhibitors, β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils.
Ortega A; Rincón Á; Jiménez-Aliaga KL; Bermejo-Bescós P; Martín-Aragón S; Molina MT; Csákÿ AG
Bioorg Med Chem Lett; 2011 Apr; 21(8):2183-7. PubMed ID: 21441028
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease. A firm base for drug development.
De Strooper B; König G
Nature; 1999 Dec; 402(6761):471-2. PubMed ID: 10591201
[No Abstract] [Full Text] [Related]
10. Heparan sulfates demonstrate potential for Alzheimer’s disease therapy.
Hill R
Future Med Chem; 2013 Jul; 5(11):1190. PubMed ID: 24020082
[No Abstract] [Full Text] [Related]
11. [Alzheimer's disease: immunity and diagnosis].
Herrera-Rivero M; Hernández-Aguilar ME; Manzo J; Aranda-Abreu GE
Rev Neurol; 2010 Aug; 51(3):153-64. PubMed ID: 20645266
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol in Alzheimer's disease and other amyloidogenic disorders.
Harris JR; Milton NG
Subcell Biochem; 2010; 51():47-75. PubMed ID: 20213540
[TBL] [Abstract][Full Text] [Related]
13. Progress toward the discovery and development of efficacious BACE inhibitors.
Durham TB; Shepherd TA
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):776-91. PubMed ID: 17117686
[TBL] [Abstract][Full Text] [Related]
14. [Progress in the development of anti-amyloid drugs for treatment of Alzheimer's disease.].
Shitaka Y; Mitani Y; Nagakura A; Miyake A; Matsuoka N
Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):15-20. PubMed ID: 20628208
[No Abstract] [Full Text] [Related]
15. Novel pyrrolyl 2-aminopyridines as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Barnes K; Hui Y; Johnson M; Lovering F; Condon J; Fobare W; Solvibile W; Turner J; Hu Y; Manas ES; Fan K; Olland A; Chopra R; Bard J; Pangalos MN; Reinhart P; Robichaud AJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2068-73. PubMed ID: 20223661
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
Lee HG; Perry G; Zhu X; Nunomura A; Smith MA
Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097
[No Abstract] [Full Text] [Related]
17. A new BACE is for therapy of Alzheimer's disease.
Kahana J
Trends Cell Biol; 2001 May; 11(5):192. PubMed ID: 11316595
[No Abstract] [Full Text] [Related]
18. Tracking Alzheimer's.
Roberts L
US News World Rep; 1999 Nov; 127(17):73. PubMed ID: 10623301
[No Abstract] [Full Text] [Related]
19. Introduction to the special issue on Alzheimer's disease.
Pangalos MN; Randall AD
Neuropharmacology; 2010; 59(4-5):219-20. PubMed ID: 20728692
[No Abstract] [Full Text] [Related]
20. Alzheimer's disease. Bad for the heart, bad for the mind?
Marx J
Science; 2001 Oct; 294(5542):508-9. PubMed ID: 11641483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
